Log in to your IBTimes Account

close
ID
Password

Outlook Roundup: Amerigon, Monsanto



By AP
12 February 2008 @ 04:29 pm EST

Among the earnings projection stories for Tuesday, Feb. 12, from AP Financial News:

Related Topic

Get stories by e-mail on this topic.

E-mail:
Quotes
ARGN 4.13 0.08
MON 93.64 14.98
ECL 42.37 2.87
PERY 11.54 0.58
ACM 17.97 1.6
ORCT 4.49 0.04
TDC 16.57 1.35
TEVA 41.75 3.26

SYMBOL LOOKUP

NORTHVILLE, Mich. (AP) Amerigon Inc., which makes climate-controlled seats for the auto industry, on Tuesday reaffirmed revenue growth of between 30 percent and 40 percent in 2008.

ST. LOUIS (AP) Monsanto Co. increased its full-year 2008 earnings per share outlook on Tuesday, citing strong demand for its seeds and traits business as well as for Roundup and other herbicides.

ST. PAUL, Minn. (AP) Ecolab Inc., which provides cleaning and pest control services, said Tuesday it expects profit below Wall Street expectations during the first quarter.

BUFFALO, N.Y. (AP) Construction and automotive supplier Gibraltar Industries Inc. said Tuesday it expects to report fourth-quarter earnings and profit below previous forecasts as the housing and car markets continue to slump.

MIAMI (AP) Apparel maker Perry Ellis International Inc. on Tuesday said it expects fiscal fourth-quarter revenue to decline as it shifts focus to branded apparel and away from private-label products.

LOS ANGELES (AP) Aecom Technology Corp., a provider of professional technical and management support services, on Tuesday raised its fiscal 2008 earnings outlook to a range of $1.23 to $1.29 per share.

NEW YORK (AP) Israel-based Orckit Communications Ltd. said Tuesday it expects a first-quarter loss after swinging to a fourth-quarter profit.

MIAMISBURG, Ohio (AP) Database manager Teradata Corp. on Tuesday said it expects earnings and revenue to rise in 2008 on higher demand for its enterprise data warehousing and enterprise analytics services.

NEW YORK (AP) Teva Pharmaceutical Industries Ltd. said Tuesday its 2008 and 2009 profit and revenue may top Wall Street expectations, despite the generic drug maker's plan to incur significantly higher research and development costs over these years.

Copyright 2008 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

    Click!
  • Rate this article:

Comments

Post Your Comment

You must be an IBTimes member to post a comment. Login | Register


advertisement
More Industries
Banco Santander of Spain said Monday it would buy the other three-quarters stake in Sovereign Bancorp that it doesn't already own for $1.9 billion, exten...
Investors pulled back from Con-way Inc. on Monday amid a broader market rally, after the trucking company said a multi-employer pension plan wants a $619...
Shares of General Electric Co. slipped Monday after the company reported a 22 percent decline in third-quarter earnings due to softening profits at its l...

Advertisement
Corporate Website Design

Professional Website Design For Corporate - Get a Free Quote Today

advertisement
 
IBTimes.com Web
Partners
International Business Times© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives